NextRNA Therapeutics, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2022-01-27. The offering totals $50.0M, of which $23.4M was reported sold. Industry: Biotechnology.
| Name | Role | Location |
|---|---|---|
| Kenneth A Anderson | Director | Cambridge, MA |
| Andrea A Armstrong | Director | Cambridge, MA |
| Arthur A Becker | Director | Cambridge, MA |
| Alain A Cohen | Director | Cambridge, MA |
| Marc A Cohen | Director | Cambridge, MA |
| Drew A Dennison | Director | Cambridge, MA |
| Christine A Henderson | Director | Cambridge, MA |
| Susan A Langer | Director | Cambridge, MA |
| Fred A Mermelstein | Director | Cambridge, MA |
| Carl A Novina | Director | Andover, MA |
| Barry A Polisky | Director | Andover, MA |
| Elena A Prokupets | Director | Cambridge, MA |
| Malcolm A Salter | Director | Cambridge, MA |
| Dominique A Verhelle | Director | Cambridge, MA |
| Marc A Cohen | Executive Officer | Cambridge, MA |
| Julia A Novina | Executive Officer | Boston, MA |